Page 22 - Jenene Thomas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Cli

Lead program, Berubicin, successfully passed pre-planned interim futility analysis milestone with recommendation from DSMB to proceed without modification in potentially pivotal GBM studyBerubicin study enrollment completed; Topline data expected in first half of 2025Clinical progress represents important steps towa.

United statesJohn climacoAmy maheryJenene thomasPharmaceuticals fast track designation for berubicinSecurities exchangeCompany on twitterBerubicin clinical development progressCompany board of directorsExchange commissionPharmaceuticals incData safety monitoring boardOverall survivalFinancial resultsFull yearFast track designation

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJenene thomasAmy maheryJohn climacoPharmaceuticals fast track designation for berubicinBerubicin clinical development progressSecurities exchangeCompany board of directorsExchange commissionCompany on twitterPharmaceuticals incData safety monitoring boardOverall survivalFinancial resultsFull yearFast track designation

Moleculin to Present at the MedInvest Biotech & Pharma Investor Conference

Moleculin to Present at the MedInvest Biotech & Pharma Investor Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkWalter klempJenene thomasMoleculin biotech incPrnewswire moleculin biotech incChief executive officerMedinvest biotechPharma investor conferenceNew york cityMoleculin biotechTranscription modulator

Ceapro Receives Final Court Approval for Merger with

TORONTO and EDMONTON, Alberta, March 28, 2024 (GLOBE NEWSWIRE) Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (

United statesLou gehrigJenene thomasJoel shafferAeterna zentaris incCeapro incExchange commissionEuropean commissionToronto stock exchangeAnnual reportRegistration statementUnited states securities actInvestor contactMedia contactTsx venture exchange czoCeapro inc

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference

AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkJenene thomasThomask equelsImmunotech incMedinvest biotechPharma investorChief executive officerPharma investor conference